(Q45350888)

13 December 2017

title

PRDX6 Exacerbates Dopaminergic Neurodegeneration in a MPTP Mouse Model of Parkinson's Disease (English)

1 reference

13 December 2017

1 reference

1 reference

1 reference

Hyung-Mun Yun

1

1 reference

13 December 2017

Dong Young Choi

series ordinal

2

1 reference

13 December 2017

Ki Wan Oh

series ordinal

3

1 reference

13 December 2017

Jin Tae Hong

series ordinal

4

1 reference

13 December 2017

publication date

6 September 2014

1 reference

13 December 2017

published in

Molecular Neurobiology

1 reference

13 December 2017

volume

52

1 reference

13 December 2017

issue

1

1 reference

13 December 2017

page(s)

422-431

1 reference

https://scigraph.springernature.com/pub.10.1007/s12035-014-8885-4

13 December 2017

exact match

0 references

cites work

Classic and new animal models of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8885-4

Functional changes of the basal ganglia circuitry in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8885-4

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8885-4

Proteasome inhibition and Parkinson's disease modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8885-4

Parkinson's disease: mechanisms and models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8885-4

Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8885-4

Protocol for the MPTP mouse model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8885-4

Oxidative stress and the pathogenesis of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8885-4

Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8885-4

Anti-inflammatory and neuroprotective effects of an orally active apocynin derivative in pre-clinical models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8885-4

Astrocytes and therapeutics for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8885-4

Astrocytes accumulate 4-hydroxynonenal adducts in murine scrapie and human Creutzfeldt-Jakob disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8885-4

Phospholipase A2-generated lipid mediators in the brain: the good, the bad, and the ugly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8885-4

Cellular pathology of Parkinson's disease: astrocytes, microglia and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8885-4

Acceleration of the development of Alzheimer's disease in amyloid beta-infused peroxiredoxin 6 overexpression transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8885-4

Structure, mechanism and regulation of peroxiredoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8885-4

Peroxiredoxin 6 as an antioxidant enzyme: protection of lung alveolar epithelial type II cells from H2O2-induced oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8885-4

Increased phospholipase A2 activity with phosphorylation of peroxiredoxin 6 requires a conformational change in the protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8885-4

1-Cys peroxiredoxin, a bifunctional enzyme with glutathione peroxidase and phospholipase A2 activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8885-4

Peroxiredoxin 6 phosphorylation and subsequent phospholipase A2 activity are required for agonist-mediated activation of NADPH oxidase in mouse pulmonary microvascular endothelium and alveolar macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8885-4

p67(phox) terminates the phospholipase A(2)-derived signal for activation of NADPH oxidase (NOX2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8885-4

H2O2-dependent hyperoxidation of peroxiredoxin 6 (Prdx6) plays a role in cellular toxicity via up-regulation of iPLA2 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8885-4

Hyperoxidized peroxiredoxins in peripheral blood mononuclear cells of asthma patients is associated with asthma severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8885-4

Phospholipase A(2) of peroxiredoxin 6 has a critical role in tumor necrosis factor-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8885-4

Characterization of neural cell types expressing peroxiredoxins in mouse brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8885-4

Nonselenium glutathione peroxidase in human brain : elevated levels in Parkinson's disease and dementia with lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8885-4

Mechanisms of Disease: astrocytes in neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8885-4

Phospholipase A2 in the central nervous system: implications for neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8885-4

Protective effect of quinacrine on striatal dopamine levels in 6-OHDA and MPTP models of Parkinsonism in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8885-4

A Nurr1/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8885-4

Peroxiredoxin 6 in human brain: molecular forms, cellular distribution and association with Alzheimer's disease pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8885-4

Oxidant-mediated AA release from astrocytes involves cPLA(2) and iPLA(2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8885-4

Prostaglandin E2 induces interleukin-6 synthesis in human astrocytoma cells.

21 January 2018

1 reference

12 December 2020

The basal ganglia and the initiation of movement

1 reference

12 December 2020

Thioredoxin-dependent peroxide reductase from yeast

1 reference

12 December 2020

Mice deficient in group IV cytosolic phospholipase A2 are resistant to MPTP neurotoxicity.

1 reference

12 December 2020

Roles of lipid peroxidation in modulation of cellular signaling pathways, cell dysfunction, and death in the nervous system

1 reference

12 December 2020

The role of glial reaction and inflammation in Parkinson's disease.

1 reference

12 December 2020

10.1007/S12035-014-8885-4

Identifiers

DOI

1 reference

Dimensions Publication ID

13 December 2017

1041659930

0 references

1 reference